510(k) · Cleared
ClearedSeraquest HSV Igg
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Quest Intl., Inc. · LGC Enzyme Linked Immunoabsorbent Assay, Herpes Simplex Virus, Non-Specific
Cleared on Jan 22, 1997 after a 154-day review. The FDA summary names its predicate without a number.
- Decided
- Jan 22, 1997
- Review
- 154 days
- Class
- Class II
- Product code
- LGC
- Recalls
- None
- Predicates
- 0
The FDA summary names its predicate without a number.
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LGC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | — | HSV-1 and HSV-2 Clin-ELISA™ kits, INCSTAR Corporation Named without a submission number |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
How does its category compare?
All LGC devicesLGC Enzyme Linked Immunoabsorbent Assay, Herpes Simplex Virus, Non-Specific: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · LGC
FDA has decided no LGC device since 2007.
Median 510(k) review, days · LGC
Too few LGC 510(k)s in any year since 2007 to give a median.
Recalls per year · LGC
1in 2022
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LGC
1in 2024
MAUDE reports naming product code LGC, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 1 | 4 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 4 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 1 | 1 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 1 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 4 |
| 2020 | 0 | — | 0 | 2 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 1 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 1 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
For the qualitative and semi-quantitative detection of human IgG antibodies to herpes simplex virus (type 1 or type 2) in human serum by enzyme immunoassay, to aid in the assessment of the patient's immunological response to herpes simplex virus. For manual use, or for use with the HyPrep System Plus. These reagents have not received FDA clearance for use in testing blood or plasma donors.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K963282 · printed Nov 6, 2026
Cite this page
510(k) Report. “K963282: Seraquest HSV Igg.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K963282
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Page last updated Nov 3, 2026